Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders

Medical Science Monitor

Volumn 9, Issue 10, 2003, Pages

  Bull, Gillian ^a   Shattock, Paul ^b   Whiteley, Paul ^b   Anderson, Roz ^b   Groundwater, Paul W ^b   Lough, John W ^b   Lees, George ^b  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Autism; Developmental disease markers; Diagnosis of autistic spectrum disorders; Reversed phase HPLC with UV detection; Trans indoki 3 acryloylglycine (IAG); Urinary creatinine

Indexed keywords

BIOCHEMICAL MARKER; GLYCINE DERIVATIVE; INDOLYL 3 ACRYLOYLGLYCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; RANK SUM TEST; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; URINE LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AUTISTIC DISORDER; BIOLOGICAL ASSAY; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; CREATINE; CREATININE; DEVELOPMENTAL DISABILITIES; FEMALE; GLYCINE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RAYS;

EID: 0142246333     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. American Psychiatric Association: Diagnostic criteria from DSM-IV. American Psychiatric Association. Washington, 1994
2. Wing L: Autism Spectrum Disorders. BMJ, 312: 327-328
3. Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children. JAMA, 2001; 285: 3093-3099
4. Magnusson P, Saemundsen E: Prevalence of autism in Iceland. J Autism and Develop Dis, 2001; 31: 153-163
5. Fombonne E: The epidemiology of autism: a review. Psychological Medicine, 1999; 29: 769-786
6. Anderson RJ, Bendall DJ, Garnett I et al: Identification of Indolyl-3-acryloylglycine (IAG) in the urine of people with autism. J Pharm and Pharmacol, 2002; 54: 295-298
7. Marklova E, Hais IM: Age variations of indolyl-3-acryloylglycine excretion in healthy children. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1978; 21: 521-5
8. Halvorsen K, Halvorsen S: Hartnup Disease. Pediatrics, 1963: 29
9. Verhagen A, Burbach J: Indolyl-3-acryloyl-glycine and the 'Light Band' in Chronic Polymorphous Light Dermatosis. Dermatologica, 1966; 133: 349-365
10. Szeinberg A, Bar-Or R, Pollak S et al: Observations on urinary excretion of indolylacryloyl glycine. Clin Chim Acta, 1965; 11: 506-511
11. Marklova E, Malina L, Hais M: Urinary excretion of indolyl-3-acryloylglycine in some skin affections. Clin Chem Acta, 1975; 64: 273-280
12. Dhossche et al: Elevated plasma GABA levels in autistic youngsters; stimulus for a GABA hypothesis of autism. Med Sci Monitor, 2002; 8(8): PR1-6
13. Reichelt KL, Hole K, Hamberger A et al: Biologically Active Peptide Containing Fractions in Schizophrenia and Childhood Autism. Adv Bio Psychopharm, 1981; 28: 627-643
14. Pedersen OS, Liu Y, Reichelt KL: Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines. J Peptide Res, 1999; 53: 641-646
15. Posey DJ, McDougle CJ: Pharmacotherapeutic management of autism. Exp Opin in Pharmacother, 2001; 2(4): 587-600
16. Anderson RJ, Carr K, Cairns D et al: Putting Tryptophan in the Spotlight. J Child Neurol, 2002; 17(suppl.): 35-38